Effects of antipsychotic treatment on psychopathology and motor symptoms. A placebo-controlled study in healthy volunteers

Author

VESELINOVIC, Tanja^{1 2} ; SCHORN, Holger^{1 2} ; VERNALEKEN, Ingo^{1 2} ; SCHIFFL, Katharina⁴ ; HIEMKE, Christoph⁵ ; ZERNIG, Gerald⁶ ; GUR, Ruben³ ; GRIINDER, Gerhard^{1 2}
[1] Department of Psychiatry, Psychotherapy and Psychosomatics, RWTH Aachen University, Pauwelsstrasse 30, 52074 Aachen, Germany
[2] JARA—Translational Brain Medicine, Aachen, Germany
[3] Neuropsychiatry Division, Department of Psychiatry, University of Pennsylvania and the Philadelphia Veterans Administration Medical Center, Philadelphia, PA, United States
[4] Institute of Medical Statistics, RWTH Aachen University, Aachen, Germany
[5] Department of Psychiatry and Psychotherapy, University Medical Centre Mainz, Mainz, Germany
[6] Experimental Psychiatry Unit, Department of Psychiatry and Psychotherapy, Medical University Innsbruck, Innsbruck, Austria

Source

Psychopharmacologia. 2011, Vol 218, Num 4, pp 733-748, 16 p ; ref : 2 p.1/4

CODEN

PSYPAG

ISSN

0033-3158

Scientific domain

Pharmacology drugs; Psychology, psychopathology, psychiatry

Publisher

Springer, Berlin

Publication country

Germany

Document type

Article

Language

English

Author keyword

Antipsychotics Aripiprazole Dopamine Haloperidol Healthy volunteers Psychopathology Reserpine

Keyword (fr)

Antihypertenseur Antipsychotique atypique Aripiprazole Dopamine Halopéridol Homme Individu sain Médicament Neuroleptique Pharmacothérapie Placebo Psychopathologie Psychotrope Réserpine Symptomatologie Trouble moteur Volontaire Agoniste partiel Alcaloïde Antagoniste dopamine Catécholamine Dérivé de la butyrophénone Neurotransmetteur Pathologie du système nerveux Quinolinone dérivé Récepteur dopaminergique D2 Récepteur sérotoninergique 5-HT1A Récepteur sérotoninergique 5-HT2A Traitement Trouble neurologique

Keyword (en)

Antihypertensive agent Atypical antipsychotic Aripiprazole Dopamine Haloperidol Human Healthy subject Drug Neuroleptic Pharmacotherapy Placebo Psychopathology Psychotropic Reserpine Symptomatology Motor system disorder Volunteer Partial agonist Alkaloid Dopamine antagonist Catecholamine Butyrophenone derivatives Neurotransmitter Nervous system diseases Quinolinone derivatives D2 Dopamine receptor 5-HT1A Serotonine receptor 5-HT2A serotonin receptor Treatment Neurological disorder

Keyword (es)

Antihipertensivo Antipsicótico atípico Aripiprazol Dopamina Haloperidol Hombre Individuo sano Medicamento Neuroléptico Farmacoterapia Placebo Psicopatología Psicotropo Reserpina Sintomatología Trastorno motor Voluntario Agonista parcial Alcaloide Antagonista dopamina Catecolamina Butirofenona derivado Neurotransmisor Sistema nervioso patología Quinolinona derivada Receptor dopaminérgico D2 Receptor serotoninérgico 5-HT1A Receptor serotoninérgico 5-HT2A Tratamiento Trastorno neurológico

Classification

Pascal

002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02B Neuropharmacology / 002B02B03 Psycholeptics: tranquillizer, neuroleptic.

Pascal

002 Biological and medical sciences / 002B Medical sciences / 002B17 Neurology / 002B17A Nervous system (semeiology, syndromes) / 002B17A01 Nervous system as a whole

Francis

770 Psychology. Psychoanalysis. Psychiatry / 770-E Psychopharmacology / 770-E03 Psycholeptics: tranquillizer, neuroleptic…

Discipline

Neurology Pharmacological treatments Psychopathology. Psychiatry. Clinical psychology

Origin

Inist-CNRS

Database

FRANCIS ; PASCAL

INIST identifier

25245570

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS